Cyclooxygenase-2 up-regulates vascular endothelial growth factor via a protein kinase C pathway in non-small cell lung cancer

Journal of Experimental and Clinical Cancer Research

Volumn 30, Issue 1, 2011, Pages

  Luo, Honghe ^a   Chen, Zhenguang ^a   Jin, Hui ^a   Zhuang, Mei ^a   Wang, Tao ^a   Su, Chunhua ^a   Lei, Yiyan ^a   Zou, Jianyong ^a   Zhong, Beilong ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; 6 ISOPROPOXY 9 OXO 2 XANTHENECARBOXYLIC ACID; CYCLOOXYGENASE 2; KT 5720; PHORBOL 13 ACETATE 12 MYRISTATE; PROSTAGLANDIN E2; PROTEIN KINASE C; PROTEIN KINASE C INHIBITOR; RO 318425; TETRAZOLIUM; UNCLASSIFIED DRUG; VASCULOTROPIN; 6-ISOPROPOXY-9-OXOXANTHENE-2-CARBOXYLIC ACID; CARBAZOLE DERIVATIVE; CYCLIC AMP DEPENDENT PROTEIN KINASE; ENZYME ACTIVATOR; PROSTAGLANDIN E; PYRROLE DERIVATIVE; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN; XANTHONE DERIVATIVE;

ADULT; AGED; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVATION; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PATHOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION; BIOSYNTHESIS; CELL SURVIVAL; DRUG ANTAGONISM; DRUG POTENTIATION; LUNG TUMOR; METABOLISM; MIDDLE AGED; TUMOR CELL CULTURE; UPREGULATION;

ADULT; AGED; CARBAZOLES; CARCINOMA, NON-SMALL-CELL LUNG; CELL SURVIVAL; CYCLIC AMP-DEPENDENT PROTEIN KINASES; CYCLOOXYGENASE 2; ENZYME ACTIVATORS; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PROSTAGLANDINS E; PROTEIN KINASE C; PYRROLES; TETRADECANOYLPHORBOL ACETATE; TUMOR CELLS, CULTURED; UP-REGULATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A; XANTHONES;

EID: 78650973558     PISSN: None     EISSN: 17569966     Source Type: Journal    
DOI: 10.1186/1756-9966-30-6     Document Type: Article

References (31)

1. Cyclooxygenases: structural, cellular, and molecular biology. WL Smith DL DeWitt RM Garavito, Annu Rev Biochem 2000 69 145 82 10.1146/annurev.biochem.69. 1.145 10966456
2. Cyclooxygenases: new forms, new inhibitors, and lessons from the clinic. TD Warner JA Mitchell, FASEB J 2004 18 790 804 10.1096/fj.03-0645rev 15117884
3. Increased cyclooxygenase 2 (COX-2) expression occurs frequently in precursor lesions of human adenocarcinoma of the lung. Y Hosomi T Yokose Y Hirose R Nakajima K Nagai Y Nishiwaki A Ochiai, Lung Cancer 2000 30 73 81 10.1016/S0169-5002(00)00132-X 11086200
4. Expression of cyclooxygenase-2 in human lung carcinoma. H Wolff K Saukkonen S Anttila A Karjalainen H Vainio A Ristimäki, Cancer Res 1998 58 4997 5001 9823297
5. Increased expression of cyclooxygenase 2 occurs frequently in human lung cancers, specifically in adenocarcinomas. T Hida Y Yatabe H Achiwa H Muramatsu K Kozaki S Nakamura M Ogawa T Mitsudomi T Sugiura T Takahashi, Cancer Res 1998 58 3761 4 9731479
6. Cyclooxygenase-2 inhibition decreases primary and metastatic tumor burden in a murine model of orthotopic lung adenocarcinoma. CA Diperna RD Bart EM Sievers Y Ma VA Starnes RM Bremner, J Thorac Cardiovasc Surg 2003 126 4 1129 33 10.1016/S0022-5223(03)00790-6 14566258
7. Prognostic significance and clinicopathological associations of COX-2 SNP in patients with nonsmall cell lung cancer. PP Grimminger J Stöhlmacher D Vallböhmer PM Schneider AH Hölscher R Metzger PV Danenberg J Brabender, J Oncol 2009 139590 Epub 2009 Nov 22 20016751
8. COX-2 is expressed in human pulmonary, colonic, and mammary tumors. RA Soslow AJ Dannenberg D Rush BM Woerner KN Khan J Masferrer AT Koki, Cancer 2000 89 12 2637 45 10.1002/1097-0142(20001215)89:12<2637::AID-CNCR173.0.CO;2-B 11135226
9. Expression of cyclooxygenase-2 in human lung carcinoma. H Wolff K Saukkonen S Anttila A Karjalainen H Vainio A Ristimaki, Cancer Research 1998 58 22 4997 5001 9823297
10. Cyclooxygenase-2 (COX-2) mRNA expression levels in normal lung tissues, and nonsmall cell lung cancers. M Ochiai T Oguri T Isobe S Ishioka M Yamakido, Jpn J Cancer Res 1999 90 1338 43 10665651
11. Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential. M Tsujii S Kawano RN DuBois, Proc Natl Acad Sci USA 1997 94 3336 40 10.1073/pnas.94.7.3336 9096394
12. Cyclooxygenase, lipoxygenase and tumor angiogenesis. D Nie KV Honn, Cell Mol Life Sci 2002 59 799 807 10.1007/s00018-002-8468-9 12088280
13. Thromboxane A(2) regulation of endothelial cell migration, angiogenesis, and tumor metastasis. D Nie M Lamberti A Zacharek L Li K Szekeres K Tang Y Chen KV Honn, Biochem Biophys Res Commun 2000 267 245 51 10.1006/bbrc.1999.1840 10623605
14. International Union Against Cancer (UICC) TNM classification of malignant tumors. LH Sobin C Wittekind, New York, NY: Wiley-Liss 6 2002 99 103
15. WHO classification of tumors. Pathology and Genetics. Tumors of lung, pleura, thymus and heart. WD Travis E Brambilla HK Muller-Hermelink, IARC Press, Lyon 2004 9 124
16. Membrane prostaglandin E synthase-1: a novel therapeutic target. B Samuelsson R Morgenstern PJ Jakobsson, Pharmacol Rev 2007 59 3 207 24 10.1124/pr.59.3.1 17878511
17. Angiogenic factors. J Folkman M Klagsbrun, Science 1987 235 442 7 10.1126/science.2432664 2432664
18. Mechanism and its regulation of tumor-induced angiogenesis. MK Gupta RY Qin, World J Gastroenterol 2003 9 6 1144 55 12800214
19. Molecular biomarkers of colorectal carcinogenesis and their role in surveillance and early intervention. G Garcea RA Sharma A Dennison WP Steward A Gescher DP Berry, Eur J Cancer 2003 39 1041 52 10.1016/S0959-8049(03)00027-3 12736102
20. VEGF-C and COX-2 expression in papillary thyroid cancer. P Siironen A Ristimäki K Narko S Nordling J Louhimo S Andersson R Haapiainen C Haglund, Endocrine-Related Cancer 2006 13 465 73 10.1677/erc.1.01114 16728574
21. Induction of cyclooxygenase-2 by Epstein-Barr virus latent membrane protein 1 is involved in vascular endothelial growth factor production in nasopharyngeal carcinoma cells. S Murono H Inoue T Tanabe I Joab T Yoshizaki M Furukawa JS Pagano, PNAS 2001 98 12 6905 10 10.1073/pnas.121016998 11381123
22. New targets for the modulation of radiation response - selective inhibition of the enzyme cyclooxygenase 2. C Petersen M Baumann S Petersen, Curr Med Chem Anticancer Agents 2003 3 5 354 9 10.2174/1568011033482314 12871081
23. Prostaglandin E2 activates mitogen-activated protein kinase/Erk pathway signaling and cell proliferation in non-small cell lung cancer cells in an epidermal growth factor receptor-independent manner. K Krysan KL Reckamp H Dalwadi S Sharma E Rozengurt M Dohadwala SM Dubinett, Cancer Res 2005 65 14 6275 81 10.1158/0008-5472.CAN-05-0216 16024629
24. Cyclooxygenase-independent down-regulation of multidrug resistance-associated protein-1 expression by celecoxib in human lung cancer cells. HK Kang E Lee H Pyo SJ Lim, Mol Cancer Ther 2005 4 9 1358 63 10.1158/1535-7163.MCT-05-0139 16170027
25. Expression of cyclooxygenase-2 in human lung carcinoma. H Wolff K Saukkonen S Anttila A Karjalainen H Vainio A Ristimäki, Cancer Res 1998 58 4997 5001 9823297
26. Cyclooxygenase-2 inhibition by celecoxib reduces proliferation and induces apoptosis in angiogenic endothelial cells in vivo. KM Leahy RL Ornberg Y Wang BS Zweifel AT Koki JL Masferrer, Cancer Res 2002 62 3 625 31 11830509
27. 716 mouse intestinal polyps. H Seno M Oshima T Ishikawa H Oshima K Takaku T Chiba S Narumiya M Taketo, Cancer Res 2002 62 506 511 11809702
28. Prostaglandin E2 stimulates human lung carcinoma cell growth through induction of integrin-linked kinase: the involvement of EP4 and Sp1. Y Zheng JD Ritzenthaler X Sun J Roman S Han, Cancer Res 2009 69 3 896 904 10.1158/0008-5472.CAN-08-2677 19176380
29. Prostaglandin E2 promotes migration and adhesion in hepatocellular carcinoma cells. R Mayoral A Fernndez-Martínez L Bosc P Martín-Sanz, Carcinogenesis 2005 26 4 753 61 10.1093/carcin/bgi022 15661807
30. Activation of prostaglandin E2-receptor EP2 and EP4 pathways induced growth inhibition in human gastric carcinoma cell lines. T Okuyama S Ishihara H Sato Ma Rumi K Kawashima Y Miyaola H Suetsugu H Kazumori CF Cava Y Kadowaki R Fukuda Y Kinoshita, J Lab Clin Med 2002 140 92 102 12228765
31. Focusing Downstream in Lung Cancer Prevention:15-Hydroxyprostaglandin Dehydrogenase. SM Dubinett JT Mao S Hazra, Cancer Prev Res 2008 1 4 223 5 10.1158/1940-6207.CAPR-08-0148